Syneos Health Releases 2023 Environmental, Social and Governance Report
juillet 8, 2024
MORRISVILLE, N.C., juillet 8, 2024 - Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today released its 2023 Environmental, Social and Governance (ESG) Report. The Report highlights the Company’s continued commitment to acting responsibly and sustainably to enable customers to improve the health of patients worldwide.
“At Syneos Health, ESG principles are embedded in our work practices, influencing the way we support our customers deliver life-changing therapies,” said Colin Shannon, CEO, Syneos Health. “I’m proud of how we continue to prioritize these efforts to strengthen our Company, drive customer results and contribute to the communities where we work and live.”
Report Highlights:
- Faire progresser la santé: Recognized in PM360’s annual Innovation issue for the use of data and technology to accelerate site selection, site activation and patient enrollment.
- Prendre soin des autres: Received 95 out of 100 on 2023 Human Rights Campaign Corporate Equality Index in second year of participation.
- Agir de manière responsable: Published a Policy for Use of Artificial Intelligence (AI) to promote responsible and ethical use of AI technologies.
- Protéger la planète: Introduced a global environmental policy and committed to setting emission reduction goals in line with the Science Based Target initiative’s criteria.
Access the full 2023 ESG Report to learn more about the Company’s purposeful actions to uphold our responsibility to create a more sustainable world for each other.
About Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. Nous traduisons des perspectives cliniques, d’affaires médicales et commerciales uniques en résultats qui répondent aux réalités du marché actuel.
We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health soutient une culture diversifiée, équitable et inclusive qui prend soin des collègues, des clients, des patients, des collectivités et de l’environnement.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.
Press/Media Contact:
Meg Byers
Associate Director, External Communications
+1 607 215 1330
